Evidence map›Paper›PMID 38620739›Full record

ArticleAnales de pediatria (Barcelona, Spain : 2003)2021

[COVID-19: Critical appraisal of the evidence].

Paz González Rodríguez, Begoña Pérez-Moneo Agapito, María Salomé Albi Rodríguez, Pilar Aizpurua Galdeano, María Aparicio Rodrigo, María Mercedes Fernández Rodríguez, María Jesús Esparza Olcina, Carlos Ochoa Sangrador, en representación del Grupo de Trabajo de Pediatría Basada en la Evidencia de la AEP y AEPap

Abstract readEnglish Abstract
In one paragraph

Article in Anales de pediatria (Barcelona, Spain : 2003), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Atencion primaria · 2023
    Article
  3. [Main changes in the «COVID-19 in paediatrics» clinical practice guideline].Anales de pediatria (Barcelona, Spain : 2003) · 2022
    Article
  4. Article
  5. Observational
  6. [COVID-19 clinical features in primary care: COVIDPAP study].Anales de pediatria (Barcelona, Spain : 2003) · 2022
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Paz González RodríguezCentro de Salud Barrio del Pilar, Madrid, España.
Begoña Pérez-Moneo AgapitoHospital Universitario Infanta Leonor, Madrid, España.
María Salomé Albi RodríguezHospital Universitario 12 de Octubre, Madrid, España.
Pilar Aizpurua GaldeanoCentro de Salud Ondarreta, San Sebastián, Guipúzcoa, España.
María Aparicio RodrigoCentro de Salud Entrevías, Madrid, España.
María Mercedes Fernández RodríguezCentro de Salud Potes, Madrid, España.
María Jesús Esparza OlcinaAtención Primaria, Madrid, España.
Carlos Ochoa SangradorComplejo Asistencial de Zamora, Zamora, España.
en representación del Grupo de Trabajo de Pediatría Basada en la Evidencia de la AEP y AEPap

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We present the summary of a critical appraisal document of the available evidence on COVID-19, developed with a clinical practice guide format following GRADE methodology. The document tries to provide answers to a series of structured clinical questions, with an explicit definition of the population, intervention/exposure, comparison and outcome, and a rating of the clinical relevance of the outcome measures. We conducted a systematic review of the literature to answer the questions, grouped into six chapters: epidemiology, clinical practice, diagnosis, treatment, prevention, and vaccination. We assessed the risk of bias of the selected studies with standard instruments (RoB-2, ROBINS-I, QUADAS and Newcastle-Ottawa). We constructed evidence tables and, when necessary and possible, meta-analysis of the of the most relevant outcome measures. We followed the GRADE system to synthesize the evidence, assessing its quality, and, when appropriate, giving recommendations, rated according to the quality of the evidence, the values and preferences, the balance between benefits, risks and costs, equity and feasibility.

Indexed as

COVID-19DiagnosisEpidemiologyEvidence-based medicinePediatricsPrevention and controlSigns and symptomsTreatmentVaccines

Identifiers

PMID38620739
PMCPMC8173476

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.